NewAmsterdam Pharma Co N.V. ($NAMS)
Filing Information
| Accession Number | 0001193125-25-335513 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 29, 2025 |
| Document Date | Dec 23, 2025 |
| Document | View SEC Filing |
Transactions
11
Total Shares
435,000
Total Value
$6,651,240.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Ordinary Shares | โ | Dec 23, 2025 | Exercise/Conversion | 75,117 | $10.00 | $751,170.00 | 90,117 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 23, 2025 | Sale | 75,117 | $36.21 | $2,719,986.57 | 15,000 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 24, 2025 | Exercise/Conversion | 26,011 | $10.00 | $260,110.00 | 41,011 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 24, 2025 | Sale | 26,011 | $35.68 | $928,072.48 | 15,000 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 26, 2025 | Exercise/Conversion | 38,872 | $10.00 | $388,720.00 | 53,872 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 26, 2025 | Exercise/Conversion | 5,000 | $10.90 | $54,500.00 | 58,872 | Direct | โ | View Details | |
Chief Accounting Officer | Ordinary Shares | โ | Dec 26, 2025 | Sale | 43,872 | $35.30 | $1,548,681.60 | 15,000 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Dec 23, 2025 | Exercise/Conversion | 75,117 | $0.00 | $0.00 | 204,898 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Dec 24, 2025 | Exercise/Conversion | 26,011 | $0.00 | $0.00 | 178,887 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Dec 26, 2025 | Exercise/Conversion | 38,872 | $0.00 | $0.00 | 140,015 | Direct | โ | View Details | |
Chief Accounting Officer | Option (right to buy) | Derivative | Dec 26, 2025 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 218,134 | Direct | โ | View Details |